[go: up one dir, main page]

AU2003227944A1 - Ddah modulators in the treatment of pain - Google Patents

Ddah modulators in the treatment of pain

Info

Publication number
AU2003227944A1
AU2003227944A1 AU2003227944A AU2003227944A AU2003227944A1 AU 2003227944 A1 AU2003227944 A1 AU 2003227944A1 AU 2003227944 A AU2003227944 A AU 2003227944A AU 2003227944 A AU2003227944 A AU 2003227944A AU 2003227944 A1 AU2003227944 A1 AU 2003227944A1
Authority
AU
Australia
Prior art keywords
ddah
modulators
pain
treatment
ddah modulators
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003227944A
Inventor
Karl Peter Giese
Keiko Mizuno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College London
Original Assignee
University College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College London filed Critical University College London
Publication of AU2003227944A1 publication Critical patent/AU2003227944A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0004Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003227944A 2002-05-16 2003-05-15 Ddah modulators in the treatment of pain Abandoned AU2003227944A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0211295.1 2002-05-16
GBGB0211295.1A GB0211295D0 (en) 2002-05-16 2002-05-16 Treatment of pain
PCT/GB2003/002122 WO2003097085A1 (en) 2002-05-16 2003-05-15 Ddah modulators in the treatment of pain

Publications (1)

Publication Number Publication Date
AU2003227944A1 true AU2003227944A1 (en) 2003-12-02

Family

ID=9936848

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003227944A Abandoned AU2003227944A1 (en) 2002-05-16 2003-05-15 Ddah modulators in the treatment of pain

Country Status (3)

Country Link
AU (1) AU2003227944A1 (en)
GB (1) GB0211295D0 (en)
WO (1) WO2003097085A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9096663B2 (en) 2001-02-15 2015-08-04 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof
US7381701B2 (en) 2001-02-15 2008-06-03 The Borad Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
US7556810B2 (en) 2005-07-19 2009-07-07 The Board Of Trustees Of The University Of Ilinois Compositions and methods to control angiogenesis with cupredoxins
CN101437842A (en) 2004-10-07 2009-05-20 阿南达·查克拉博蒂 Cupredoxin derived transport formulations and methods of use thereof
US9968685B2 (en) 2004-10-07 2018-05-15 Brad N. Taylor Methods to treat cancer with cupredoxins
US9598470B2 (en) 2004-10-07 2017-03-21 Craig W. Beattie Compositions and methods to prevent cancer by stabilizing P53 through non MDM2-mediated pathways
US10675326B2 (en) 2004-10-07 2020-06-09 The Board Of Trustees Of The University Of Illinois Compositions comprising cupredoxins for treating cancer
US9434770B2 (en) 2004-10-07 2016-09-06 Tapas K Das Gupta Modified cupredoxin derived peptides
US8063104B2 (en) 2004-11-12 2011-11-22 Ucl Business Plc Guanidine derivatives as inhibitors of DDAH
JP2009502135A (en) 2005-07-19 2009-01-29 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ Transport factors for crossing the blood-brain barrier and into brain cancer cells and methods of use thereof
AU2008212788A1 (en) 2007-02-08 2008-08-14 The Board Of Trustees Of The University Of Illinois Compositions and methods to prevent cancer with cupredoxins
EP2398486A4 (en) * 2009-02-20 2012-11-21 Cdg Therapeutics Inc Compositions and methods to prevent and/or treat cancer with pa -card

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1144605B1 (en) * 1999-01-26 2009-12-16 University College London Dimethylarginine dimethylaminohydrolases
US20030138803A1 (en) * 2001-07-27 2003-07-24 Brooksbank Robert Alan Identification and use of molecules implicated in pain

Also Published As

Publication number Publication date
GB0211295D0 (en) 2002-06-26
WO2003097085A1 (en) 2003-11-27

Similar Documents

Publication Publication Date Title
AU2003202196A1 (en) Devices and methods for heart valve treatment
AU2003300791A1 (en) Combination therapy for the treatment of pain
AU2003283257A1 (en) Scalp treatment
AU2003202075A1 (en) Modulator of the notch signalling pathway and use thereof in medical treatment
AU2003226537A1 (en) Modulators of the notch signalling pathway and uses thereof in medical treatment
AU2003227944A1 (en) Ddah modulators in the treatment of pain
GB0213869D0 (en) The treatment of pain
AU2002319286A1 (en) Skin treatment
AU2002352566A1 (en) Use of corrinoids in the treatment of skin diseases
AU2003293500A1 (en) Lactoferrin in the reduction of pain
IL164951A0 (en) The treatment of pain with lfendropil
AU2003233998A1 (en) Ddah modulators in the treatment of pain
AU2003268939A1 (en) Bisphosphonates for the treatment of antheroscleorosis and devices comprising them
AU2003275433A1 (en) Compositions and methods for treating pain
AU2003904303A0 (en) Nerve function and tissue healing
AU2003240446A1 (en) Use of mob-5 in pain
AU2003215725A1 (en) Materials and methods relating to the treatment of lymphoma
AU2003217432A1 (en) Angiopoietin-1 in the treatment of disease
AU2003273817A1 (en) Increasing of the resorption of substances via skin and mucous membranes
HK1072713A (en) The treatment of pain with ifenprodil
AU2003293714A1 (en) Methods for the treatment of chronic pain and compositions therefor
AU2002324184A1 (en) Use of a lentiviral vector in the treatment of pain
GB0325957D0 (en) The treatment of pain
GB0216978D0 (en) The treatment of pain
AU2003208829A1 (en) Beta-amino ketones for the treatment of pain

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase